<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJNeph</journal-id><journal-title-group><journal-title>Open Journal of Nephrology</journal-title></journal-title-group><issn pub-type="epub">2164-2842</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojneph.2020.101006</article-id><article-id pub-id-type="publisher-id">OJNeph-98804</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Non-Infectious Complications of Peritoneal Dialysis in Senegal
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ahmed</surname><given-names>Tall Lemrabott</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Maria</surname><given-names>Faye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Moustapha</surname><given-names>Faye</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdoul</surname><given-names>Hassane Sanlé Traoré</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mouhamadou</surname><given-names>Moustapha Cissé</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Khodia</surname><given-names>Fall</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Yaya</surname><given-names>Kane</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zeinabou</surname><given-names>Maiga Moussa Tondi</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mansour</surname><given-names>Mbengue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bacary</surname><given-names>Ba</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Niakhalee</surname><given-names>Keita</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Seynabou</surname><given-names>Diagne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abdou</surname><given-names>Niang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boucar</surname><given-names>Diouf</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>El</surname><given-names>Hadji Fary Ka</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Internal Medicine and Nephrology, Assane Seck University, Ziguinchor, Senegal</addr-line></aff><aff id="aff1"><addr-line>Department of Nephrology, Aristide Le Dantec University Hospital, Dakar, Senegal</addr-line></aff><aff id="aff2"><addr-line>Department of Nephrology, Thies University, Thies, Senegal</addr-line></aff><aff id="aff4"><addr-line>Department of Nephrology and Haemodialysis, Faculty of Sciences and Health of the Abdou Moumouni University of Niamey, Niamey, Niger</addr-line></aff><pub-date pub-type="epub"><day>22</day><month>01</month><year>2020</year></pub-date><volume>10</volume><issue>01</issue><fpage>43</fpage><lpage>49</lpage><history><date date-type="received"><day>11,</day>	<month>February</month>	<year>2020</year></date><date date-type="rev-recd"><day>9,</day>	<month>March</month>	<year>2020</year>	</date><date date-type="accepted"><day>12,</day>	<month>March</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Introduction: Senegal has pioneered the implementation of peritoneal dialysis (PD) in West Africa, practicing it since 2004. Non-infectious complications are a significant cause of failure of this technique and the transfer of patients to haemodialysis. The aim of this study was to determine the prevalence and the different types of non-infectious complications in our context. 
  Patients and Methods: This was a 5-year, descriptive, retrospective study of patients on chronic peritoneal dialysis for more than 3 months. 
  Results: During the study period, 75 patients were included. The prevalence of non-infectious complications was 88%, including 45.3% mechanical complications and 76% metabolic complications. Catheter migration was the most common mechanical complication (55.9%), followed by catheter blockage (23.5%). Metabolic complications were dominated by hypoalbuminemia (76.3%). Dyslipidaemia and hypokalaemia affected more than 50% of patients, occurring in 59.3% and 56.9% of cases, respectively. 
  Conclusion: In our study, non-infectious complications related to PD were frequent and varied. They remain a significant cause of technical failure. Mechanical complications are often the cause of permanent transfer to haemodialysis.
 
</p></abstract><kwd-group><kwd>Peritoneal Dialysis</kwd><kwd> Non-Infectious Complications</kwd><kwd> Catheter Migration</kwd><kwd> Hypoalbuminemia</kwd><kwd> Hypokalaemia</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Peritoneal dialysis (PD) is the least used extrarenal cleansing technique; it only involves 11% of dialysis patients, with great variability between the different regions; despite the definite advantages, both in terms of the autonomy it provides and its accessibility to the most fragile patients [<xref ref-type="bibr" rid="scirp.98804-ref1">1</xref>].</p><p>Non-infectious complications are secondary to the implementation of the DP catheter in the peritoneal cavity, the increase in intra-abdominal pressure by the dialysate, and the metabolic effects of absorption of glucose and its by-products. Mechanical complications are frequent and represent around 20% of hemodialysis transfers. Prevention, early recognition and proper management of these complications are paramount due to patient-related morbidity and technique failure [<xref ref-type="bibr" rid="scirp.98804-ref2">2</xref>].</p><p>In Senegal, PD has been practiced since 2004. It involves around 12% of patients in extrarenal treatment. This low level of patient management by this technique is partly linked to the occurrence of complications. Besides the most frequent and serious infectious complications, non-infectious complications represent a non-negligible cause of failure (8% to 20% transition to haemodialysis) [<xref ref-type="bibr" rid="scirp.98804-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.98804-ref4">4</xref>]. These complications are mechanical and metabolic.</p><p>Since the implementation of this technique in Senegal, no study has focused specifically on non-infectious complications of PD. Therefore, we conducted this study, which aims to determine the prevalence and the types of non-infectious complications in our PD unit.</p></sec><sec id="s2"><title>2. Patients and Methods</title><p>This is a retrospective and descriptive study conducted in the peritoneal dialysis unit of the nephrology, dialysis and renal transplant department of the Aristide Le Dantec teaching hospital in Dakar (Senegal), over a period of 5 years, from 1 January 2013 to 31 December 2017. We included all patients who underwent peritoneal dialysis treatment for at least 3 months for chronic kidney disease at stage 5D. PD patients for acute renal failure and patients on vacation in Senegal were not included.</p><p>Data were collected from patients’ medical records. For each patient included, the following parameters were studied: age, sex, causal nephropathy, PD procedures and clinical and biological parameters, notably albuminemia, glycemia, total cholesterolaemia, HDL-cholesterolaemia, LDL-cholesterolaemia and triglyceridaemia, were collected.</p><p>For each type of mechanical and metabolic non-infectious complication, we collected the average age of patients and the average time to onset compared with the start of PD.</p><p>In terms of equipment, the Tenckhoff double-sleeve catheter was used on all patients. The catheter was placed by the surgical method by a non-dedicated urological surgeon. The techniques used were continuous ambulatory peritoneal dialysis (CAPD) and continuous cycling peritoneal dialysis (CCPD). For CAPD, a BAXTER&#174; type disconnectable double pocket system was used. Glucose bags (physioneal&#174;) of 1.36%, 2.27% and 3.86%, icodextrin (Extraneal&#174;) and amino acids (Nutrineal&#174;) were used.</p><p>Mechanical complications were defined by the appearance of complications due to the catheter after its insertion and/or due to the presence of intraperitoneal fluid. Metabolic complications were those attributable to PD (hypokalaemia, hyperglycaemia, hypoalbuminemia, dyslipidaemia).</p><p>The collected data were analysed by using IBM SPSS Statistics version 25 software. Qualitative variables are presented as a percentage, and quantitative variables are presented as an average plus or minus the standard deviation or with a minimum and a maximum.</p></sec><sec id="s3"><title>3. Results</title><p>• Study population</p><p>During the study period, 84 patients benefited from the placement of a peritoneal dialysis catheter. Nine patients were not included due to unusable medical records. The study thus involved 75 patients, of whom 57 were on CAPD and 18 were on CCPD. There were 30 men (40%) and 45 women (60%), for a sex ratio of 0.66. The mean patient age was 48.6 &#177; 14.4 years.</p><p>Seventy-one patients (94.7%) were hypertensive, and 7 patients (9.3%) were diabetic. The first causative agent of nephropathy was nephroangiosclerosis in 31 patients (41.3%) (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Sixty-six patients (88%) presented at least one non-infectious complication, including 23 men (34.8%) and 43 women (65.2%). The mean age was 50.1 &#177; 13.9 years. The mean duration of PD was 18 &#177; 11 months, with extremes of 3 and 56 months.</p><p>• Mechanical complications</p><p>The number of patients who presented with at least one mechanical complication was 34, i.e. a prevalence of 45.3%. The mean age was 47.7 &#177; 12.3 years. <xref ref-type="table" rid="table2">Table 2</xref> represents the prevalence of the various mechanical complications and their average time of onset compared with the beginning of PD.</p><p>• Metabolic complications</p><p>The number of patients who presented at least one metabolic complication was 57% or 76% of the patients included. The mean age was 50.8 &#177; 13.8 years. The distribution of patients according to metabolic complications is shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s4"><title>4. Discussion</title><p>Mechanical complications in PD are frequent and remain highly variable depending on the region of the world, experience of services, type of catheter and insertion technique used.</p><p>The prevalence of mechanical complications in our study (45.3%) was slightly higher than that of the Moroccan and Pakistani studies, where the prevalence was 37% and 40%, respectively [<xref ref-type="bibr" rid="scirp.98804-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98804-ref6">6</xref>].</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Distribution of patients by cause of nephropathy</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Cause of nephropathy</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage</th></tr></thead><tr><td align="center" valign="middle" >Hypertensive nephropathy</td><td align="center" valign="middle" >31</td><td align="center" valign="middle" >41.3%</td></tr><tr><td align="center" valign="middle" >Chronic glomerulonephritis</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >24%</td></tr><tr><td align="center" valign="middle" >Chronic kidney disease of unknown aetiology</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >18.7%</td></tr><tr><td align="center" valign="middle" >Diabetic nephropathy</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >9.3%</td></tr><tr><td align="center" valign="middle" >Autosomal dominant polycystic kidney disease</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4%</td></tr><tr><td align="center" valign="middle" >Chronic tubulointerstitial nephritis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3%</td></tr><tr><td align="center" valign="middle" >Cortical necrosis</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3%</td></tr></tbody></table></table-wrap><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Mechanical complications and their average time of onset</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Types of mechanical complications</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage in population of PD</th><th align="center" valign="middle" >Average time of onset (months)</th></tr></thead><tr><td align="center" valign="middle" >Catheter migration</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >25.3%</td><td align="center" valign="middle" >5.8 &#177; 8.7</td></tr><tr><td align="center" valign="middle" >Catheter obstruction</td><td align="center" valign="middle" >8</td><td align="center" valign="middle" >10.7%</td><td align="center" valign="middle" >11.7 &#177; 11.4</td></tr><tr><td align="center" valign="middle" >Accidental cutting</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8%</td><td align="center" valign="middle" >13.5 &#177; 8.9</td></tr><tr><td align="center" valign="middle" >Bend in the catheter</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8%</td><td align="center" valign="middle" >9.2 &#177; 10</td></tr><tr><td align="center" valign="middle" >Hernias</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >5.3%</td><td align="center" valign="middle" >10.8 &#177; 4.9</td></tr><tr><td align="center" valign="middle" >Bleeding of abdominal walls</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.7%</td><td align="center" valign="middle" >0.6</td></tr><tr><td align="center" valign="middle" >Hemoperitoneum</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.7%</td><td align="center" valign="middle" >7.5 &#177; 7.7</td></tr><tr><td align="center" valign="middle" >Intestinal perforation</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.3%</td><td align="center" valign="middle" >6</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Metabolic complications and their time of onset</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Types of mechanical complications</th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage in population of PD</th><th align="center" valign="middle" >Average time of onset (months)</th></tr></thead><tr><td align="center" valign="middle" >Hypoalbuminemia</td><td align="center" valign="middle" >29</td><td align="center" valign="middle" >76.3%</td><td align="center" valign="middle" >8.7 &#177; 10.7</td></tr><tr><td align="center" valign="middle" >Dyslipidaemia</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >59.3%</td><td align="center" valign="middle" >19.8 &#177;15.9</td></tr><tr><td align="center" valign="middle" >Hypokalaemia</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >56%</td><td align="center" valign="middle" >7.1 &#177; 9.3</td></tr><tr><td align="center" valign="middle" >Hyperglycaemia</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >3.7%</td><td align="center" valign="middle" >9</td></tr></tbody></table></table-wrap><p>In our series, catheter migration was found in 25.3% of cases and represented the most frequent mechanical complication (55.9% of complications). These results are corroborated by Miftah et al. [<xref ref-type="bibr" rid="scirp.98804-ref4">4</xref>], as well as Flayou et al. in Morocco [<xref ref-type="bibr" rid="scirp.98804-ref7">7</xref>], who noted a respective prevalence of 24.2% (or 65.2% of complications) and 23.6% (or 36.8% of complications).</p><p>Blockage of the catheter was noted in 10.7% of our patients. Miftah et al. [<xref ref-type="bibr" rid="scirp.98804-ref5">5</xref>] reported a higher prevalence at 13%. Huraib et al. in Saudi Arabia [<xref ref-type="bibr" rid="scirp.98804-ref8">8</xref>] found an even higher prevalence of obstruction (25% of cases).</p><p>The prevalence of hernia in our study was 5.3%, with a predominance of umbilical localization in 75% of cases. Miftah et al. [<xref ref-type="bibr" rid="scirp.98804-ref5">5</xref>], Flayou et al. [<xref ref-type="bibr" rid="scirp.98804-ref7">7</xref>], Villemain et al. in France [<xref ref-type="bibr" rid="scirp.98804-ref9">9</xref>] and Huraib et al. [<xref ref-type="bibr" rid="scirp.98804-ref8">8</xref>] found a higher prevalence at 21.7%, 12.2%, 11.8% and 10%, respectively. In PD this complication generally constitutes the recurrence of a pre-existing hernia and the number increases with age [<xref ref-type="bibr" rid="scirp.98804-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.98804-ref10">10</xref>]. In our series, patients who presented with hernia had a relatively low average age, lower than that of the other series. Furthermore, none had a history of hernia, hence this lower frequency.</p><p>Accidental cutting was found in 8% of our patients. This mechanical complication had the longest average time to onset (13.5 &#177; 8.9 months).</p><p>Miftah et al. [<xref ref-type="bibr" rid="scirp.98804-ref5">5</xref>] found a slightly lower prevalence at 6.5% after a long average delay (25.6 months). Flayou et al. [<xref ref-type="bibr" rid="scirp.98804-ref7">7</xref>] and Raina et al. in India [<xref ref-type="bibr" rid="scirp.98804-ref11">11</xref>] found a much lower prevalence of 3.4% and 2.47%, respectively. This difference in prevalence could be explained by the fact that some of the teams put the catheter in pockets that the patient carried regularly, which made it possible to protect the catheter. The other complicating factors related to the age of the catheter, the use of sharp clamps, the repeated use of disinfectants and the use of radio opaque barium sulphate catheters.</p><p>One patient presented with an intestinal perforation. Asif et al. in the USA [<xref ref-type="bibr" rid="scirp.98804-ref12">12</xref>] and Peppelenbosh et al. in Holland [<xref ref-type="bibr" rid="scirp.98804-ref13">13</xref>] found a prevalence of 0.8% and 0.9%, respectively.</p><p>Intestinal perforation is an infrequent but serious complication associated with significant morbidity and mortality [<xref ref-type="bibr" rid="scirp.98804-ref14">14</xref>]. One of the risk factors is the presence of intestinal distension, hence the value of preoperative laxatives.</p><p>Postoperative wall bleeding and hemoperitoneum were infrequent in our series. These are relatively mild complications that can be avoided by minimally invasive techniques for implanting the dialysis catheter [<xref ref-type="bibr" rid="scirp.98804-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.98804-ref16">16</xref>]. Indeed, over a period of 10 years, Vaux et al. [<xref ref-type="bibr" rid="scirp.98804-ref17">17</xref>] did not report any bleeding episodes after insertion of the catheter by the fluoroscopic method.</p><p>Regarding metabolic complications, the prevalence of hypokalaemia was 55.9%. Chuang et al. in Taiwan [<xref ref-type="bibr" rid="scirp.98804-ref18">18</xref>] noted a similar prevalence (56.8%). Hypokalaemia is a fairly common complication in PD; its prevalence varies between 10% and 58% [<xref ref-type="bibr" rid="scirp.98804-ref19">19</xref>] [<xref ref-type="bibr" rid="scirp.98804-ref20">20</xref>] and is probably influenced by differences in dietary potassium intake between countries.</p><p>In our study, the average albumin level was 27.3 &#177; 4.9 g/l, compared with 32.3 &#177; 4.3 g/l in a series by Kaysen et al. in the USA [<xref ref-type="bibr" rid="scirp.98804-ref21">21</xref>]. These differences can be explained by the overall nutritional status of patients with end-stage CKD in our context. Patients are diagnosed at advanced stages of the disease, often with poor nutritional status. This already precarious state is aggravated when the patient begins peritoneal dialysis, due to peritoneal albumin losses.</p><p>The prevalence of hypercholesterolemia was 59.3% and that of hypertriglyceridemia, 14.8%. The aetiologies of hyperlipidaemia are multifactorial. On the one hand, the significant absorption of glucose from the dialysate constitutes a substrate for the synthesis of lipoprotein, having as a corollary the rise in the plasma lipid level. On the other hand, the increased peritoneal loss of proteins (including albumin and other lipoprotein regulating substances) is the cause.</p><p>Limitations of our study lie in its retrospective aspect and the usual bias in connection with this type of study.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In our study, non-infectious complications related to peritoneal dialysis were frequent and varied. They were often the cause of definitive transfer to haemodialysis. The establishment of a therapeutic and dietetic education unit is necessary to reduce the prevalence of these complications.</p></sec><sec id="s6"><title>Acknowledgements</title><p>Our thanks to the entire urology team and the nurses in our PD unit for their involvement in the management of non-infectious PD complications.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Lemrabott, A.T., Faye, M., Faye, M., Traor&#233;, A.H.S., Ciss&#233;, M.M., Fall, K., Kane, Y., Tondi, Z.M.M., Mbengue, M., Ba, B., Keita, N., Diagne, S., Niang, A., Diouf, B. and Ka, El H.F. (2020) Non-Infectious Complications of Peritoneal Dialysis in Senegal. Open Journal of Nephrology, 10, 43-49. https://doi.org/10.4236/ojneph.2020.101006</p></sec></body><back><ref-list><title>References</title><ref id="scirp.98804-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Jain, A., Blake, P., Cordy, P., et al. (2012) Global Trends in Rates of Peritoneal Dialysis. Journal of the American Society of Nephrology, 23, 533-544. https://doi.org/10.1681/ASN.2011060607</mixed-citation></ref><ref id="scirp.98804-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">McCormick, B.B. and Bargman, J.B. (2007) Noninfectious Complications of Peritoneal Dialysis: Implications for Patient and Technique Survival. Journal of the American Society of Nephrology, 18, 3023-3025. https://doi.org/10.1681/ASN.2007070796</mixed-citation></ref><ref id="scirp.98804-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kolesnyk, I., Dekker, F., Boeschoten, E., et al. (2010) Time-Dependent Reasons for Peritoneal Dialysis Technique Failure and Mortality. Peritoneal Dialysis International, 30, 170-177. https://doi.org/10.3747/pdi.2008.00277</mixed-citation></ref><ref id="scirp.98804-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Brown, E., Van Biesen, W., Finkelstein, F., et al. (2009) Length of Time on Peritoneal Dialysis and Encapsulating Peritoneal Sclerosis: Position Paper for ISPD. Peritoneal Dialysis International, 29, 595-600. https://doi.org/10.1177/089686080902900602</mixed-citation></ref><ref id="scirp.98804-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Miftah, M., Asseban, M., Bezzaz, A., et al. (2014) Mechanical Complications of Peritoneal Dialysis. Open Journal of Nephrology, 4, 103-109. https://doi.org/10.4236/ojneph.2014.43015</mixed-citation></ref><ref id="scirp.98804-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Prakash, J., Singh, S., Shreeniwas, S., et al. (2011) Non-Infectious Complications of Continuous Ambulatory Peritoneal Dialysis and Their Impact on Technique Survival. Indian Journal of Nephrology, 21, 112-115. https://doi.org/10.4103/0971-4065.82125</mixed-citation></ref><ref id="scirp.98804-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Flayou, K., Ouzeddoun, N., Bayahia, R., et al. (2016) Mechanical Complications of Continuous Ambulatory Peritoneal Dialysis: Experience at the Ibn Sina University Hospital. Saudi Journal of Kidney Diseases and Transplantation, 27, 107-110. https://doi.org/10.4103/1319-2442.174089</mixed-citation></ref><ref id="scirp.98804-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Huraib, S., Abu-Aisha, H., Memon, N., et al. (1995) Non-Peritonitis Complications of Continuous Ambulatory Peritoneal Dialysis in Saudi Arabia. Annals of Saudi Medicine, 15, 458-461. https://doi.org/10.5144/0256-4947.1995.458</mixed-citation></ref><ref id="scirp.98804-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Villemain, F., Ryckelynck, J., Lobbedez, T., et al. (2002) Complications abdominales en dialyse péritonéale. Néphrologie, 23, 237-243.</mixed-citation></ref><ref id="scirp.98804-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Gotloib, L., Mines, M., Garmizo, L., et al. (1981) Hemodynamic Effects of Increasing Intra-Abdominal Pressure in Peritoneal Dialysis. Peritoneal Dialysis International, 1, 41-43. https://doi.org/10.1177/089686088000100406</mixed-citation></ref><ref id="scirp.98804-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Raina, A., Saleem, S., Jan, S., et al. (2017) Mechanical Complications of Continuous Ambulatory Peritoneal Dialysis: A Hospital Based Retrospective Study in Kashmir Valley. Archives of Medicine and Health Sciences, 5, 21-23.</mixed-citation></ref><ref id="scirp.98804-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Asif, A., Byers, P., Vieira, C., et al. (2003) Peritoneoscopic Placement of Peritoneal Dialysis Catheter and Bowel Perforation: Experience of an Interventional Nephrology Program. American Journal of Kidney Diseases, 42, 1270-1274. https://doi.org/10.1053/j.ajkd.2003.08.029</mixed-citation></ref><ref id="scirp.98804-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Peppelenbosch, A., Van Kuijk, W.H.M., et al. (2008) Peritoneal Dialysis Catheter Placement Technique and Complications. NDT Plus, 1, iv23-iv28. https://doi.org/10.1093/ndtplus/sfn120</mixed-citation></ref><ref id="scirp.98804-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wakeen, M., Zimmerman, S. and Bidwell, D. (1994) Viscus Perforation in Peritoneal Dialysis Patients: Diagnosis and Outcome. Peritoneal Dialysis International, 14, 371-377. https://doi.org/10.1177/089686089401400411</mixed-citation></ref><ref id="scirp.98804-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Gadallah, M., Pervez, A., el-Shahawy, M., et al. (1999) Peritoneoscopic versus Surgical Placement of Peritoneal Dialysis Catheters: A Prospective Randomized Study on Outcome. American Journal of Kidney Diseases, 33, 118-122. https://doi.org/10.1016/S0272-6386(99)70266-0</mixed-citation></ref><ref id="scirp.98804-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Wright, M., Bel’eed, K., Johnson, B., et al. (1999) Randomized Prospective Comparison of Laparoscopic and Open Peritoneal Dialysis Catheter Insertion. Peritoneal Dialysis International, 19, 372-375. https://doi.org/10.1177/089686089901900415</mixed-citation></ref><ref id="scirp.98804-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Vaux, E., Torrie, P., Barker, L., et al. (2008) Percutaneous Fluoroscopically Guided Placement of Peritoneal Dialysis Catheters: A 10-Year Experience. Seminars in Dialysis, 21, 459-465. https://doi.org/10.1111/j.1525-139X.2008.00463.x</mixed-citation></ref><ref id="scirp.98804-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Chuang, Y., Shu, K., Yu, T., et al. (2009) Hypokalemia: An Independent Risk Factor of Enterobacteria Peritonitis in CAPD Patients. Nephrology Dialysis Transplantation, 24, 1603-1608. https://doi.org/10.1093/ndt/gfn709</mixed-citation></ref><ref id="scirp.98804-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Tziviskou, E., Musso, C., Bellizzi, V., et al. (2003) Prevalence and Pathogenesis of Hypokalemia in Patients on Chronic Peritoneal Dialysis: One Center’s Experience and Review of the Literature. International Urology and Nephrology, 35, 429-434. https://doi.org/10.1023/B:UROL.0000022867.93739.03</mixed-citation></ref><ref id="scirp.98804-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Khan, A., Bernardini, J., Johnston, J., et al. (1996) Hypokalemia in Peritoneal Dialysis Patients. Peritoneal Dialysis International, 16, 652. https://doi.org/10.1177/089686089601600628</mixed-citation></ref><ref id="scirp.98804-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Kaysen, G., Rathore, V., Shearer, G., et al. (1995) Mechanisms of Hypoalbuminemia in Hemodialysis Patients. Kidney International, 48, 510-516. https://doi.org/10.1038/ki.1995.321</mixed-citation></ref></ref-list></back></article>